In vitro effects of the CCR5 inhibitor maraviroc on human T cell function

Author： Arberas H.   Guardo A. C.   Bargalló M. E.   Maleno M. J.   Calvo M.   Blanco J. L.   García F.   Gatell J. M.   Plana M.  

Publisher： Oxford University Press

ISSN： 1460-2091

Source： Journal of Antimicrobial Chemotherapy, Vol.68, Iss.3, 2013-03, pp. : 577-586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on D-Ala-Peptide T-Amide (DAPTA): A Viral Entry Inhibitor that Blocks CCR5 Chemokine Receptors

By  

Current HIV Research, Vol. 1, Iss. 1, 2003-01 ,pp. : 51-67

Bentham Science Publishers

Access to resources Recommend Favorite

Better CD4+ T Cell Recovery in Brazilian HIV-Infected Individuals Under HAART Due to Cumulative Carriage of SDF-1-3'A, CCR2-V64I, CCR5- D32 and CCR5-Promoter 59029A/G Polymorphisms

By  

Current HIV Research, Vol. 6, Iss. 5, 2008-09 ,pp. : 466-473

Bentham Science Publishers

Access to resources Recommend Favorite

PRO 140 - A Novel CCR5 Co-Receptor Inhibitor

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 18-22

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of urinary gonadotrophin preparations on human in-vitro immune function

By Biffoni M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2430-2434

Oxford University Press

Access to resources Recommend Favorite

In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells

By  

Current Immunology Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 57-75

Bentham Science Publishers

Access to resources Recommend Favorite